{
  "ticker": "ABBV",
  "company_name": "AbbVie Inc.",
  "sector": "Healthcare",
  "industry": "Drug Manufacturers - General",
  "analysis_date": "2025-12-18",
  "business_quality_score": 10,
  "financial_health_score": 7.1,
  "valuation_score": 3,
  "growth_score": 1,
  "sentiment_score": 7,
  "institutional_score": 9.0,
  "risk_score": 8.8,
  "conviction_score": 64.9,
  "conviction_tier": "MEDIUM",
  "bull_case": "Quality healthcare company with high quality business, strong balance sheet",
  "bear_case": "Expensive valuation",
  "market_cap": 393808642048,
  "pe_ratio": 168.80302,
  "debt_to_equity": null,
  "profit_margin": 0.04004,
  "revenue_growth": 0.091,
  "current_price": 222.82,
  "analyst_target": 244.68036,
  "recommendation": "buy",
  "position_size_modifier": 1.149
}